Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Antidepressant effect of the first electroconvulsive therapy with ketamine and/or propofol.
Caffeine, creatine, GRIN2A and Parkinson's disease progression.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Caffeine, creatine, GRIN2A and Parkinson's disease progression.
Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci. 2017 Apr 15; 375:355-359.
View in:
PubMed
subject areas
Aged
Caffeine
Creatine
Disease Progression
Female
Gene-Environment Interaction
Genetic Predisposition to Disease
Genotype
Humans
Longitudinal Studies
Male
Middle Aged
Parkinson Disease
Polymorphism, Single Nucleotide
Receptors, N-Methyl-D-Aspartate
authors with profiles
Barbara C. Tilley